These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35617800)
21. Genetic deletion of calcium/calmodulin-dependent protein kinase type II delta does not mitigate adverse myocardial remodeling in volume-overloaded hearts. Mohamed BA; Elkenani M; Jakubiczka-Smorag J; Buchholz E; Koszewa S; Lbik D; Schnelle M; Hasenfuss G; Toischer K Sci Rep; 2019 Jul; 9(1):9889. PubMed ID: 31285482 [TBL] [Abstract][Full Text] [Related]
22. CRABP1 protects the heart from isoproterenol-induced acute and chronic remodeling. Park SW; Persaud SD; Ogokeh S; Meyers TA; Townsend D; Wei LN J Endocrinol; 2018 Mar; 236(3):151-165. PubMed ID: 29371236 [TBL] [Abstract][Full Text] [Related]
23. Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. Liu N; Ruan Y; Denegri M; Bachetti T; Li Y; Colombi B; Napolitano C; Coetzee WA; Priori SG J Mol Cell Cardiol; 2011 Jan; 50(1):214-22. PubMed ID: 20937285 [TBL] [Abstract][Full Text] [Related]
24. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Wu Y; Temple J; Zhang R; Dzhura I; Zhang W; Trimble R; Roden DM; Passier R; Olson EN; Colbran RJ; Anderson ME Circulation; 2002 Sep; 106(10):1288-93. PubMed ID: 12208807 [TBL] [Abstract][Full Text] [Related]
25. The combined inhibition of the CaMKIIδ and calcineurin signaling cascade attenuates IGF-IIR-induced cardiac hypertrophy. Chen CH; Lin JW; Huang CY; Yeh YL; Shen CY; Badrealam KF; Ho TJ; Padma VV; Kuo WW; Huang CY J Cell Physiol; 2020 Apr; 235(4):3539-3547. PubMed ID: 31584202 [TBL] [Abstract][Full Text] [Related]
27. Distinct roles of calmodulin and Ca Wang S; Li J; Liu Y; Zhang J; Zheng X; Sun X; Lei S; Kang Z; Chen X; Lei M; Hu H; Zeng X; Hao L Biochem Biophys Res Commun; 2020 Jun; 526(4):960-966. PubMed ID: 32303334 [TBL] [Abstract][Full Text] [Related]
28. Sustained increased CaMKII phosphorylation is involved in the impaired regression of isoproterenol-induced cardiac hypertrophy in rats. Li J; Gao Q; Wang S; Kang Z; Li Z; Lei S; Sun X; Zhao M; Chen X; Jiao G; Hu H; Hao L J Pharmacol Sci; 2020 Sep; 144(1):30-42. PubMed ID: 32665128 [TBL] [Abstract][Full Text] [Related]
29. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors. Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578 [TBL] [Abstract][Full Text] [Related]
30. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias. Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705 [TBL] [Abstract][Full Text] [Related]